NuVasive, Inc. NUVA

Full chart Compare
Set alert

Price alert · NUVA

All alert types
39.75 0.00 (+0.00%)

At closeAug 31, 2023, 4:00 PM EDT

39.51 Day range 40.96

52-week range unavailable

Market cap
2.26B
Revenue (ttm)
1.22B
Profit margin
1.66%
Shares out
52.45M
Forward P/E
16.86
Volume
30.59M
Open
40.62
Previous close
39.75
Day's range
39.51 – 40.96
Beta
1.07
Analysts
Hold
Price target
48.73 (+22.6%)
Earnings date
Aug 2, 2023

2Y -18.92 (-32.25%)

405060Jan 22May 22Oct 22Feb 23Jul 2339.75

Key statistics

Enterprise value
3.11B
PEG ratio
1.05
Price / sales
1.86
Price / book
2.59
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
5.80%
Free cash flow
17.42M
Total cash
181.20M
Total debt
1.01B
Return on equity
2.40%
Short % of float
16.38%
50-day average
40.46
200-day average
41.49

Financials — quick view

All financials
NUVA Revenue — quarterly 317.79M
2019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023
NUVA Net income — quarterly 7.36M
2019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023
NUVA EPS — quarterly 0.14
2019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023

Earnings

NUVA recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 2, 2023Jun 1, 20230.56———
May 10, 2023Mar 1, 20230.41———
Feb 22, 2023Dec 1, 20220.49———
Nov 9, 2022Sep 1, 20220.53———
Aug 3, 2022Jun 1, 20220.55———
May 4, 2022Mar 1, 20220.38———

Upgrades / downgrades

NUVA analyst upgrades and downgrades
DateFirmActionFromTo
May 31, 2023Morgan StanleymainEqual-WeightEqual-Weight
May 15, 2023RBC CapitalreitOutperformOutperform
May 12, 2023BarclaysmainOverweightOverweight
May 11, 2023RBC CapitalreitOutperformOutperform
May 11, 2023Morgan StanleymainEqual-WeightEqual-Weight
Feb 23, 2023JP Morganmain—Neutral

About NuVasive, Inc.

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
nuvasive.com

News

Your note

Sign in to keep a note on NUVA — it syncs with the Stock Master app.

Insider holders

NUVA insider holders
InsiderRelationLatest transactionDateShares held
BARRY JAMES CHRISTOPHERChief Executive OfficerConversion of Exercise of derivative securityFeb 28, 202372,997
CALAFIORE MASSIMOOfficerConversion of Exercise of derivative securityFeb 28, 20227,207
FARRINGTON MICHAELOfficerConversion of Exercise of derivative securityFeb 28, 20233,117
HARBAUGH MATTHEW KChief Financial OfficerConversion of Exercise of derivative securityFeb 28, 202310,522
KADIA SIDDHARTHADirectorConversion of Exercise of derivative securityMay 26, 20223,739
NORWALK LESLIE VDirectorConversion of Exercise of derivative securityMay 31, 20223,095

Institution ownership

NUVA institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.80%8,809,702380.23MMar 30, 2023
Vanguard Group, Inc. (The)11.31%5,933,898256.11MMar 30, 2023
State Street Corporation4.09%2,143,31992.51MMar 30, 2023
Macquarie Group Limited4.08%2,142,03092.45MMar 30, 2023
Magnetar Financial LLC3.39%1,778,83176.77MMar 30, 2023
Dimensional Fund Advisors LP2.98%1,561,85567.41MMar 30, 2023

Fund ownership

NUVA fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF7.55%3,953,828170.65MFeb 27, 2023
Vanguard Total Stock Market Index Fund3.01%1,578,10068.11MDec 30, 2022
Vanguard Small-Cap Index Fund2.57%1,343,10557.97MDec 30, 2022
iShares Russell 2000 ETF2.19%1,146,96449.50MFeb 27, 2023
Thrivent Mid Cap Stock Fund2.16%1,131,43748.83MJan 30, 2023
Delaware Group Equity Fds V-Small Cap Core Fund1.93%1,012,84943.71MNov 29, 2022